Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 159

The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.

Platelets, immune cells and the coagulation cascade; friend or foe of the circulating tumour cell?

Open access
Ward, Mark P., E. Kane, Laura, A. Norris, Lucy, Mohamed, Bashir M., Kelly, Tanya, Bates, Mark, Clarke, Andres, Brady, Nathan, Martin, Cara M., Brooks, Robert D., Brooks, Doug A., Selemidis, Stavros, Hanniffy, Sean, Dixon, Eric P., A. O’Toole, Sharon, J. O’Leary, John · 2021 · Molecular Cancer

Abstract

Cancer cells that transit from primary tumours into the circulatory system are known as circulating tumour cells (CTCs). These cancer cells have unique phenotypic and genotypic characteristics which allow them to survive within the circulation, subsequently extravasate and metastasise. CTCs have emerged as a useful diagnostic tool using “liquid biopsies” to report on the metastatic potential of cancers. However, CTCs by their nature interact with components of the blood circulatory system on a constant basis, influencing both their physical and morphological characteristics as well as metastatic capabilities. These properties and the associated molecular profile may provide critical diagnostic and prognostic capabilities in the clinic. Platelets interact with CTCs within minutes of their dissemination and are crucial in the formation of the initial metastatic niche. Platelets and coagulation proteins also alter the fate of a CTC by influencing EMT, promoting pro-survival signalling and aiding in evading immune cell destruction. CTCs have the capacity to directly hijack immune cells and utilise them to aid in CTC metastatic seeding processes. The disruption of CTC clusters may also offer a strategy for the treatment of advance staged cancers. Therapeutic disruption of these heterotypical interactions as well as direct CTC targeting hold great promise, especially with the advent of new immunotherapies and personalised medicines. Understanding the molecular role that platelets, immune cells and the coagulation cascade play in CTC biology will allow us to identify and characterise the most clinically relevant CTCs from patients. This will subsequently advance the clinical utility of CTCs in cancer diagnosis/prognosis.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/s12943-021-01347-1

Cites

9 of 9 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 9 references

Cited by

See all 159

Metadata

Authors
Ward, M. P., E. Kane, L., A. Norris, L., Mohamed, B. M., Kelly, T., Bates, M., Clarke, A., Brady, N., Martin, C. M., Brooks, R. D., Brooks, D. A., Selemidis, S., Hanniffy, S., Dixon, E. P., A. O’Toole, S., & J. O’Leary, J.
Venue
Molecular Cancer
Published
2021-03-31
Volume
20
Issue
1
Pages
59-59
ISSN
1476-4598 (ISSN-L)
OpenAlex
W3150102637
Cited by
159
References
9
FWCI
9.38
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Platelets, immune cells and the coagulation cascade; friend or foe of the circulating tumour cell? https://app.cochat.ai/papers/10.1186/s12943-021-01347-1
The paper
Ward, M. P., E. Kane, L., A. Norris, L., Mohamed, B. M., Kelly, T., Bates, M., Clarke, A., Brady, N., Martin, C. M., Brooks, R. D., Brooks, D. A., Selemidis, S., Hanniffy, S., Dixon, E. P., A. O’Toole, S., & J. O’Leary, J. (2021). Platelets, immune cells and the coagulation cascade; friend or foe of the circulating tumour cell? Molecular Cancer. https://doi.org/10.1186/s12943-021-01347-1

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.